Our Team

Our founder-led, interdisciplinary team has been involved in the approval of 25 drugs and the investigation of more than 100.

Leadership

Amit Etkin, MD, PhD

Founder and Chief Executive Officer

Dan Segal

Co-Founder and Chief Strategy Officer

Adam Savitz, MD, PhD

Chief Medical Officer

Wei Wu, PhD

Co-Founder and Chief Data Science Officer

Nick Smith

Chief Financial Officer

Erin R. McQuade, JD

General Counsel and Chief Administrative Officer

Jessica Powell

Chief Development Officer

Fadi Abdel, PhD

Senior Vice President, Innovation

Melissa Berman

Vice President, Finance and Accounting

Bruce Morimoto, PhD

Vice President, Drug Development

Scientific Advisors

Tom Insel, MD

Former Director, NIMH

Madhukar Trivedi, MD

Professor, UTSW

Alan Schatzberg, MD

Professor, Stanford

Fei-Fei Li, PhD

Professor, Stanford

Quentin Huys, PhD

Professor, University College London

Board of Directors

Amit Etkin, MD, PhD

Founder and Chief Executive Officer

Dan Segal

Co-Founder and Chief Strategy Officer

Gwill York, MBA

Founding Managing Director, Lighthouse Capital Partners

Aaron Weaver

Principal, Apeiron Investment Group

Jeff Chen, PhD

Managing Director, Alkeon Capital Management

Christopher Nixon Cox, JD

CEO, Lightswitch Capital

Chris Dimitropoulos

Managing Director, Alpha Wave Global

Receive updates from Alto
Thanks for signing up!
Oops! Something went wrong while submitting the form.